1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology
3. Executive Summary
3.1. Global Market Size (US$ Mn) and Forecast, by Region, 2023 and 2033
3.2. Global Market: Market Snapshot
4. Market Overview
4.1. Global Market Overview
4.2. Global Market Key Industry Developments
4.3. Key Industry Events
5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Key Trends
5.6. Global Market Revenue Projections (US$ Mn), 2023–2033
5.7. Market: Mergers & Acquisitions
5.8. Heat Map Analysis – Company
6. Global Market Analysis, by Test Type
6.1. Introduction
6.2. Key Insights
6.3. Global Market Size and Forecast, by Test Type
6.3.1. Prenatal Testing Services
6.3.2. New Born Screening
6.3.3. Predictive and Presymptomatic Testing
6.3.4. Pharmacogenomic Testing
6.3.5. Others
6.4. Global Market Analysis, by Test Type
6.5. Global Market Attractiveness Analysis, by Test Type
7. Global Market Analysis, by Service Providers
7.1. Introduction
7.2. Key Insights
7.3. Global Market Size and Forecast, by Service Providers
7.3.1. Hospital Based Laboratories
7.3.2. Diagnostic laboratories
7.3.3. Specialty Clinics
7.3.4. Others
7.4. Global Market Analysis, by Service Providers
7.5. Global Market Attractiveness Analysis, by Service Providers
8. Global Market Analysis, by Applications
8.1. Introduction
8.2. Key Insights
8.3. Global Market Size and Forecast, by Applications
8.3.1. Oncology
8.3.2. Infectious Diseases
8.3.3. Autoimmune Diseases
8.3.4. Others
8.4. Global Market Analysis, by Applications
8.5. Global Market Attractiveness Analysis, by Applications
9. Global Market Analysis, by Region
9.1. Introduction
9.2. Key Insights
9.3. Global Market Size and Forecast , by Region, 2023–2033
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East & Africa
9.4. Global Market Analysis, by Region
9.5. Global Market Attractiveness Analysis, by Region
10. North America Market Analysis
10.1. North America Market Key Findings
10.2. North America Market Overview
10.3. North America Market Size and Forecast, by Test Type
10.3.1. Prenatal Testing Services
10.3.2. New Born Screening
10.3.3. Predictive and Presymptomatic Testing
10.3.4. Pharmacogenomic Testing
10.3.5. Others
10.3.6. North America Market Analysis, by Test Type
10.4. North America Market Size and Forecast, by Service Providers
10.4.1. Hospital Based Laboratories
10.4.2. Diagnostic laboratories
10.4.3. Specialty Clinics
10.4.4. Others
10.5. North America Market Forecast, by Applications
10.5.1. Oncology
10.5.2. Infectious Diseases
10.5.3. Autoimmune Diseases
10.5.4. Others
10.6. North America Market Forecast, by Country
10.6.1. U.S.
10.6.2. Canada
10.7. North America Market Attractiveness Analysis
10.7.1. By Test Type
10.7.2. By Service Providers
10.7.3. By Applications
10.7.4. By Country
11. Europe Market Analysis
11.1. Europe Market Key Findings
11.2. Europe Market Overview
11.3. Europe Market Size and Forecast, by Test Type
11.3.1. Prenatal Testing Services
11.3.2. New Born Screening
11.3.3. Predictive and Presymptomatic Testing
11.3.4. Pharmacogenomic Testing
11.3.5. Others
11.4. Europe Market Size and Forecast, by Service Providers
11.4.1. Hospital Based Laboratories
11.4.2. Diagnostic laboratories
11.4.3. Specialty Clinics
11.4.4. Others
11.5. Europe Market Forecast, by Applications
11.5.1. Oncology
11.5.2. Infectious Diseases
11.5.3. Autoimmune Diseases
11.5.4. Others
11.6. Europe Market Forecast, by Country
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Spain
11.6.5. Italy
11.6.6. Rest of Europe
11.7. Europe Market Attractiveness Analysis
11.7.1. By Test Type
11.7.2. By Service Providers
11.7.3. By Applications
11.7.4. By Country
12. Asia Pacific Market Analysis
12.1. Asia Pacific Market Key Findings
12.2. Asia Pacific Market Overview
12.3. Asia Pacific Cytometry Market Size and Forecast, by Test Type
12.3.1. Prenatal Testing Services
12.3.2. New Born Screening
12.3.3. Predictive and Presymptomatic Testing
12.3.4. Pharmacogenomic Testing
12.3.5. Others
12.4. Asia Pacific Market Size and Forecast, by Service Providers
12.4.1. Hospital Based Laboratories
12.4.2. Diagnostic laboratories
12.4.3. Specialty Clinics
12.4.4. Others
12.5. Asia Pacific Market Forecast, by Applications
12.5.1. Oncology
12.5.2. Infectious Diseases
12.5.3. Autoimmune Diseases
12.5.4. Others
12.6. Asia Pacific Market Forecast, by Country
12.6.1. China
12.6.2. India
12.6.3. Japan
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Asia Pacific Market Attractiveness Analysis
12.7.1. By Test Type
12.7.2. By Service Providers
12.7.3. By Applications
12.7.4. By Country
13. Latin America Market Analysis
13.1. Latin America Market Key Findings
13.2. Latin America Market Overview
13.3. Latin America Cytometry Market Size and Forecast, by Test Type
13.3.1. Prenatal Testing Services
13.3.2. New Born Screening
13.3.3. Predictive and Presymptomatic Testing
13.3.4. Pharmacogenomic Testing
13.3.5. Others
13.4. Latin America Market Size and Forecast, by Service Providers
13.4.1. Hospital Based Laboratories
13.4.2. Diagnostic laboratories
13.4.3. Specialty Clinics
13.4.4. Others
13.5. Latin America Market Forecast, by Country
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Market Forecast, by Applications
13.6.1. Oncology
13.6.2. Infectious Diseases
13.6.3. Autoimmune Diseases
13.6.4. Others
13.7. Latin America Market Attractiveness Analysis
13.7.1. By Test Type
13.7.2. By Service Providers
13.7.3. By Applications
13.7.4. By Country
14. Middle East & Africa Market Analysis
14.1. Middle East & Africa Market Key Findings
14.2. Middle East & Africa Market Overview
14.3. Middle East & Africa Cytometry Market Size and Forecast, by Test Type
14.3.1. Prenatal Testing Services
14.3.2. New Born Screening
14.3.3. Predictive and Presymptomatic Testing
14.3.4. Pharmacogenomic Testing
14.3.5. Others
14.4. Middle East & Africa Market Size and Forecast, by Service Providers
14.4.1. Hospital Based Laboratories
14.4.2. Diagnostic laboratories
14.4.3. Specialty Clinics
14.4.4. Others
14.5. Middle East & Africa Market Forecast, by Applications
14.5.1. Oncology
14.5.2. Infectious Diseases
14.5.3. Autoimmune Diseases
14.5.4. Others
14.6. Middle East & Africa Market Size and Forecast, by Country
14.6.1. GCC Countries
14.6.2. Israel
14.6.3. South Africa
14.6.4. Rest of Middle East & Africa
14.7. Middle East Market Attractiveness Analysis
14.7.1. By Test Type
14.7.2. By Service Providers
14.7.3. By Applications
14.7.4. By Country
15. Competition Landscape
15.1. Global Market Share Analysis, by Company (2022)
15.2. Company Profiles
15.2.1. Laboratory Corporation of America Holdings
15.2.1.1. Overview (HQ, Employee Strength, Business Segments)
15.2.1.2. Financials
15.2.1.3. Recent Developments
15.2.1.4. Strategy
15.2.2. Quest Diagnostics Incorporated
15.2.2.1. Overview (HQ, Employee Strength, Business Segments)
15.2.2.2. Financials
15.2.2.3. Recent Developments
15.2.2.4. Strategy
15.2.3. Genomic Health, Inc.
15.2.3.1. Overview (HQ, Employee Strength, Business Segments)
15.2.3.2. Financials
15.2.3.3. Recent Developments
15.2.3.4. Strategy
15.2.4. NeoGenomics Laboratories, Inc.
15.2.4.1. Overview (HQ, Employee Strength, Business Segments)
15.2.4.2. Financials
15.2.4.3. Recent Developments
15.2.4.4. Strategy
15.2.5. Eurofins Scientific
15.2.5.1. Overview (HQ, Employee Strength, Business Segments)
15.2.5.2. Financials
15.2.5.3. Recent Developments
15.2.5.4. Strategy
15.2.6. Ambry Genetics
15.2.6.1. Overview (HQ, Employee Strength, Business Segments)
15.2.6.2. Financials
15.2.6.3. Recent Developments
15.2.6.4. Strategy
15.2.7. F. Hoffmann-La Roche Ltd
15.2.7.1. Overview (HQ, Employee Strength, Business Segments)
15.2.7.2. Financials
15.2.7.3. Recent Developments
15.2.7.4. Strategy
15.2.8. Illumina, Inc
15.2.8.1. Overview (HQ, Employee Strength, Business Segments)
15.2.8.2. Financials
15.2.8.3. Recent Developments
15.2.8.4. Strategy
15.2.9. CENTOGENE AG
15.2.9.1. Overview (HQ, Employee Strength, Business Segments)
15.2.9.2. Financials
15.2.9.3. Recent Developments
15.2.9.4. Strategy
15.2.10. 23andMe, Inc.
15.2.10.1. Overview (HQ, Employee Strength, Business Segments)
15.2.10.2. Financials
15.2.10.3. Recent Developments
15.2.10.4. Strategy
Table 01: Global Market Value (US$ Mn) Forecast, by Test Type, 2023–2033Table 02: Global Market Value (US$ Mn) Forecast, by Service Provider, 2023–2033
Table 03: Global Market Value (US$ Mn) Forecast, by Applications, 2023–2033
Table 04: Global Market Size (US$ Mn) Forecast, by Region, 2023–2033
Table 05: North America Market Value (US$ Mn) Forecast, by Test Type, 2023–2033
Table 06: North America Market Value (US$ Mn) Forecast, by Service Providers,
Table 07: North America Market Value (US$ Mn) Forecast, by Applications,
Table 08: North America Market Value (US$ Mn) Forecast, by Country, 2023–2033
Table 09: Europe Market Value (US$ Mn) Forecast, by Test Type, 2023–2033
Table 10: Europe Market Value (US$ Mn) Forecast, by Service Providers,
Table 11: Europe Market Value (US$ Mn) Forecast, by Applications,
Table 12: Europe Market Value (US$ Mn) Forecast, by Country, 2023–2033
Table 13: Asia Pacific Market Value (US$ Mn) Forecast, by Test Type, 2023–2033
Table 14: Asia Pacific Market Value (US$ Mn) Forecast, by Service Providers,
Table 15: Asia Pacific Market Value (US$ Mn) Forecast, by Applications,
Table 16: Asia Pacific Market Value (US$ Mn) Forecast, by Country, 2023–2033
Table 17: Latin America Market Value (US$ Mn) Forecast, by Test Type, 2023–2033
Table 18: Latin America Market Value (US$ Mn) Forecast, by Service Providers,
Table 19: Latin America Market Value (US$ Mn) Forecast, by Applications,
Table 20: Latin America Market Value (US$ Mn) Forecast, by Country, 2023–2033
Table 21: Middle East & Africa Market Value (US$ Mn) Forecast, by Test Type, 2023–2033
Table 22: Middle East & Africa Market Value (US$ Mn) Forecast, by Service Providers,
Table 23: Middle East & Africa Market Value (US$ Mn) Forecast, by Service Applications
Table 24: Middle East & Africa Market Value (US$ Mn) Forecast, by Country, 2023–2033
